Rucaparib camsylate - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic sources for rucaparib camsylate and what is the scope of patent protection?
Rucaparib camsylate
is the generic ingredient in one branded drug marketed by Clovis Oncology Inc and is included in one NDA. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.Rucaparib camsylate has two hundred and seventy-nine patent family members in fifty-three countries.
One supplier is listed for this compound.
Summary for rucaparib camsylate
International Patents: | 279 |
US Patents: | 12 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 25 |
Clinical Trials: | 6 |
Patent Applications: | 11 |
DailyMed Link: | rucaparib camsylate at DailyMed |
Recent Clinical Trials for rucaparib camsylate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alliance for Clinical Trials in Oncology | Phase 3 |
National Cancer Institute (NCI) | Phase 3 |
Clovis Oncology, Inc. | Phase 2 |
Pharmacology for rucaparib camsylate
Drug Class | Poly(ADP-Ribose) Polymerase Inhibitor |
Mechanism of Action | Poly(ADP-Ribose) Polymerase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for rucaparib camsylate
US Patents and Regulatory Information for rucaparib camsylate
International Patents for rucaparib camsylate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Cyprus | 1110335 | See Plans and Pricing | |
Argentina | 080164 | SALES Y POLIMORFOS DE 8-FLUORO-2-{4-[(METILAMINO)METIL]FENIL}-1,3,4,5-TETRAHIDRO-6H-ACEPINO[5,4,3-CD]INDOL-6-ONA | See Plans and Pricing |
South Africa | 200507097 | Phthalazinone derivatives | See Plans and Pricing |
Slovenia | 1660095 | See Plans and Pricing | |
Eurasian Patent Organization | 009469 | ПРОИЗВОДНЫЕ ФТАЛАЗИНОНА (PHTHALAZINONE DERIVATIVES) | See Plans and Pricing |
Russian Federation | 2006105652 | ТРИЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ ПАРП | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for rucaparib camsylate
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1633724 | 596 | Finland | See Plans and Pricing | |
1633724 | 2015/016 | Ireland | See Plans and Pricing | PRODUCT NAME: OLAPARIB, AND SALTS AND SOLVATES THEREOF; REGISTRATION NO/DATE: EU/1/14/959/001 20141216 |
2534153 | 2018039 | Norway | See Plans and Pricing | PRODUCT NAME: RUKAPARIBKAMSYLAT; REG. NO/DATE: EU/1/17/1250 20180531 |
1633724 | 15C0022 | France | See Plans and Pricing | PRODUCT NAME: OLAPARIB,SELS ET SOLVATES DE CELUI-CI; REGISTRATION NO/DATE: EU 1/14/959 20141218 |
1633724 | CR 2015 00012 | Denmark | See Plans and Pricing | PRODUCT NAME: OLAPARIB, OG SALTE OG SOLVATER DERAF; REG. NO/DATE: EU/1/14/959/001 20141216 |
2534153 | 300958 | Netherlands | See Plans and Pricing | PRODUCT NAME: RUCAPARIB CAMSYLAAT; REGISTRATION NO/DATE: EU/1/17/1250 20180529 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.